Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. (SHA:600436)
116.60
-0.71 (-0.61%)
Sep 16, 2026, 3:00 PM CST
SHA:600436 Revenue
Zhangzhou Pientzehuang Pharmaceutical had revenue of 1.83B CNY in the quarter ending June 30, 2026, a decrease of -18.12%. This brings the company's revenue in the last twelve months to 8.20B, down -22.06% year-over-year. In the year 2025, Zhangzhou Pientzehuang Pharmaceutical had annual revenue of 9.00B, down -16.56%.
Revenue (ttm)
8.20B
Revenue Growth
-22.06%
P/S Ratio
8.58
Revenue / Employee
2.84M
Employees
2,886
Market Cap
70.35B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.00B | -1.79B | -16.56% |
| Dec 31, 2024 | 10.79B | 729.37M | 7.25% |
| Dec 31, 2023 | 10.06B | 1.36B | 15.69% |
| Dec 31, 2022 | 8.69B | 672.45M | 8.38% |
| Dec 31, 2021 | 8.02B | 1.51B | 23.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Nanjing Pharmaceutical Group Company | 54.82B |
| Zhejiang Int'l Group | 34.20B |
| Sichuan Kelun Pharmaceutical | 18.27B |
| Yifan Pharmaceutical | 4.97B |
| Zhejiang Jolly Pharmaceutical Co.,LTD | 3.21B |
| GuangYuYuan Chinese Herbal Medicine | 1.41B |
| Zhejiang Wolwo Bio-Pharmaceutical | 1.09B |
| Shanghai InnoStar Bio-tech | 901.08M |
Zhangzhou Pientzehuang Pharmaceutical News
- 19 days ago - Zhangzhou Pientzehuang Pharmaceutical Quarterly report: H1 2026 - Filings
- 4 months ago - Zhangzhou Pientzehuang Pharmaceutical Annual report: H2 2025 - Filings
- 4 months ago - Zhangzhou Pientzehuang Pharmaceutical Quarterly report: Q1 2026 - Filings
- 11 months ago - Zhangzhou Pientzehuang Pharmaceutical Quarterly report: Q3 2025 - Filings